Quick Facts

• Nike named Pfizer CFO David Denton as its new Executive Vice President and CFO, effective August 17, replacing Matthew Friend who has held the role since April 2020.
• Denton will receive a $1.45 million base salary, an $11.5 million long-term incentive target, and more than $11 million in one-time cash awards to compensate for forfeited pay from prior roles.
• Nike shares fell 1.88% to $42.38 on the announcement, leaving the stock down 33% year to date.

Nike on June 23 named David Denton as its next chief financial officer, pulling the Pfizer finance chief into a sportswear company still fighting through a protracted turnaround. Denton, 60, replaces Matthew Friend, who will step down August 17 after more than six years in the role.

Friend will remain with the company through September 4 and will participate in Nike’s fourth quarter fiscal 2026 earnings call on June 30.

Denton brings more than 30 years of finance experience, including stints as CFO at Lowe’s and CVS Health. He joined Pfizer as finance chief in May 2022 and also served on the boards of Haleon and Tapestry.

CEO Elliott Hill framed the transition as a deliberate step forward. ‘This is a natural moment for a leadership transition as we move from foundational actions to sustained growth through our Sport Offense operating model,’ Hill said.

Jefferies analyst Randall Konik backed that read. ‘We view the CFO appointment as another tangible signal that the Elliott Hill-led turnaround is progressing in measured, deliberate fashion, with the right operators being put in place to execute against a multi-year reset,’ Konik wrote. Jefferies added that bringing in a seasoned external CFO ahead of the fiscal 2027 planning cycle reflects a ‘thoughtful, paced turnaround.’

Not all analysts agreed. Needham’s Tom Nikic noted the external hire was somewhat surprising, pointing out that Nike’s past practice of going outside for top leadership, including former CEO John Donahoe, had been ‘problematic.’ Evercore ISI cautioned that the unexpected transition could create additional uncertainty as Nike executes its broader strategy.

Morningstar analyst David Swartz put the move in blunter terms. ‘There has been massive house cleaning at Nike since Hill came in as CEO,’ Swartz said. ‘The many executive changes reflect Nike’s struggles over the past few years and the slow pace of the turnaround.’

Nike’s financials remain under pressure. In the fiscal third quarter ended February 28, net income fell 32% to $520 million on revenues of $11.3 billion. Analysts expect fourth quarter earnings per share of 12 cents on revenue of $10.85 billion.

Nike said fourth quarter results will include a one-time benefit from tariff refunds not included in prior guidance. Excluding that item, results are expected to be generally in line with what the company previously projected. Telsey Advisory Group’s Cristina Fernandez estimated the refund could be in the $1 billion range, based on Nike’s earlier disclosure that tariffs would cost the company $1.5 billion annually.

BNP Paribas senior analyst Laurent Vasilescu noted the timing of the CFO announcement, just before quarterly earnings, could signal Nike is again preparing to cut annual guidance. Multiple analysts also raised the possibility that Nike will postpone its fall investor day given the leadership change.

Denton’s compensation package reflects the stakes. Beyond his $1.45 million base salary and $11.5 million long-term incentive target for fiscal 2027, Nike will pay him a one-time cash award of more than $7 million on his first payroll date and a $4 million performance-based cash award vesting December 10, 2027, to offset forfeited compensation from his prior roles.

Wall Street currently holds a Moderate Buy consensus on Nike stock, with 10 Buy ratings and 15 Hold ratings assigned over the past three months. The company reports fourth quarter results June 30.

Read more: Nike’s surprise CFO change ‘another tangible signal’ of turnaround progress